Hims & Hers Health shares fall over 7% as technical selling pressure dominates

Traders Union
All News
Financial News
Hims & hers slides 7.24% today

Highlights

Hims & Hers trades below its short-term average after a 7.24% drop, signaling heightened intraday volatility and initial selling pressure.
Momentum signals remain broadly bullish, with buyers maintaining dominance, but some exhaustion and near-term caution are indicated.
Key support lies at $32.4 and resistance at $36.55, with a strong probability of price holding between these levels over the next week.

Anton Kharitonov, expert at Traders Union, sees rising technical risk in Hims & Hers Health Inc as the stock breaks below its 20-day moving average. He notes that medium- and long-term trends offer some support but warns that heightened volatility and overbought momentum signals point to further downside. News catalysts are missing, which amplifies uncertainty and makes sentiment less predictable. Kharitonov highlights the potential for a sharp move if support at $32.4 fails. He adds, "With short-term technicals rolling over and no news-driven demand, traders should stay defensive until price action stabilizes."

Viktoras Karapetjanc, expert at Traders Union, believes that the bullish structure in Hims & Hers remains intact despite the recent dip. He sees robust underlying demand, with support at the 50- and 200-day moving averages safeguarding the uptrend. The absence of significant news means external shocks are unlikely to disrupt the momentum story. Karapetjanc says, "With the probability of an upward move over 80%, further growth is expected as the market offers multiple technical setups above $34.16."

Jainam Mehta, market strategist, points out that Hims & Hers is now trading below short-term support but retains higher-term bullish signals. He thinks mixed momentum and volatility present a tactical opportunity for nimble traders. Mehta suggests, "If price clears $36.55, a breakout long setup could emerge — but further downside may open if $32.4 gives way."

Mixed momentum and elevated volatility as technical boundaries converge

Hims & Hers is currently below its 20-day moving average at $34.71, but still holds above the 50-day ($29.58) and 200-day ($31.91) moving averages. This configuration indicates short-term weakness but ongoing medium- and long-term constructive trends, with the Ichimoku Kijun at $32.5 offering support. The nearest support stands at $34.16 and resistance at $34.71. Momentum signals are mixed: MACD and ADX reflect underlying buying interest and a bullish tilt, while RSI at 63.29 and CCI are elevated without triggering immediate overbought signals. Stochastic RSI reads a neutral 50.77, and BBP at 2.32 implies intraday buyer dominance, but its overbought status suggests some caution is warranted. Trading near session lows and volatility at 10.07% further highlight the pronounced intraday pressure.

Earlier, analysts noted that while Hims & Hers Health maintained a broadly positive long-term trajectory, short-term technical pressures were escalating. The latest bout of selling and the break below the 20-day moving average now highlight the importance of monitoring whether medium-term support holds, as a decisive move outside the projected volatility band could redefine momentum in the sessions ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.